Combinación farmacéutica que comprende ponesimod

Combinación farmacéutica que comprende ponesimod

LA PRESENTE INVENCIÓN SE RELACIONA CON UNA COMBINACIÓN FARMACÉUTICA QUE COMPRENDE UN PRIMER INGREDIENTE ACTIVO QUE ES PONESIMOD Y UN SEGUNDO INGREDIENTE ACTIVO QUE SE SELECCIONA DEL GRUPO QUE CONSISTE EN TERIFLUNOMIDA Y LEFLUNOMIDA. The present invention relates to a pharmaceutical combination compr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CLOZEL, Martine, POUZOL, Laetitia
Format: Patent
Sprache:spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CLOZEL, Martine
POUZOL, Laetitia
description LA PRESENTE INVENCIÓN SE RELACIONA CON UNA COMBINACIÓN FARMACÉUTICA QUE COMPRENDE UN PRIMER INGREDIENTE ACTIVO QUE ES PONESIMOD Y UN SEGUNDO INGREDIENTE ACTIVO QUE SE SELECCIONA DEL GRUPO QUE CONSISTE EN TERIFLUNOMIDA Y LEFLUNOMIDA. The present invention relates to a pharmaceutical combination comprising a first active ingredient which is ponesimod and a second active ingredient which is selected from the group consisting of teriflunomide and leflunomide.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CL2019002525A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CL2019002525A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CL2019002525A13</originalsourceid><addsrcrecordid>eNrjZDByzs9NysxLTM48vDlPIS2xKDcx-fDK0pLM5ESFwtJUheT83IKi1LyUVIWC_LzU4szc_BQeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhLv7GNkYGhpYGBkamTqaGhMnCoAR-kueg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Combinación farmacéutica que comprende ponesimod</title><source>esp@cenet</source><creator>CLOZEL, Martine ; POUZOL, Laetitia</creator><creatorcontrib>CLOZEL, Martine ; POUZOL, Laetitia</creatorcontrib><description>LA PRESENTE INVENCIÓN SE RELACIONA CON UNA COMBINACIÓN FARMACÉUTICA QUE COMPRENDE UN PRIMER INGREDIENTE ACTIVO QUE ES PONESIMOD Y UN SEGUNDO INGREDIENTE ACTIVO QUE SE SELECCIONA DEL GRUPO QUE CONSISTE EN TERIFLUNOMIDA Y LEFLUNOMIDA. The present invention relates to a pharmaceutical combination comprising a first active ingredient which is ponesimod and a second active ingredient which is selected from the group consisting of teriflunomide and leflunomide.</description><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200207&amp;DB=EPODOC&amp;CC=CL&amp;NR=2019002525A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25573,76557</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200207&amp;DB=EPODOC&amp;CC=CL&amp;NR=2019002525A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CLOZEL, Martine</creatorcontrib><creatorcontrib>POUZOL, Laetitia</creatorcontrib><title>Combinación farmacéutica que comprende ponesimod</title><description>LA PRESENTE INVENCIÓN SE RELACIONA CON UNA COMBINACIÓN FARMACÉUTICA QUE COMPRENDE UN PRIMER INGREDIENTE ACTIVO QUE ES PONESIMOD Y UN SEGUNDO INGREDIENTE ACTIVO QUE SE SELECCIONA DEL GRUPO QUE CONSISTE EN TERIFLUNOMIDA Y LEFLUNOMIDA. The present invention relates to a pharmaceutical combination comprising a first active ingredient which is ponesimod and a second active ingredient which is selected from the group consisting of teriflunomide and leflunomide.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDByzs9NysxLTM48vDlPIS2xKDcx-fDK0pLM5ESFwtJUheT83IKi1LyUVIWC_LzU4szc_BQeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhLv7GNkYGhpYGBkamTqaGhMnCoAR-kueg</recordid><startdate>20200207</startdate><enddate>20200207</enddate><creator>CLOZEL, Martine</creator><creator>POUZOL, Laetitia</creator><scope>EVB</scope></search><sort><creationdate>20200207</creationdate><title>Combinación farmacéutica que comprende ponesimod</title><author>CLOZEL, Martine ; POUZOL, Laetitia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CL2019002525A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CLOZEL, Martine</creatorcontrib><creatorcontrib>POUZOL, Laetitia</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CLOZEL, Martine</au><au>POUZOL, Laetitia</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Combinación farmacéutica que comprende ponesimod</title><date>2020-02-07</date><risdate>2020</risdate><abstract>LA PRESENTE INVENCIÓN SE RELACIONA CON UNA COMBINACIÓN FARMACÉUTICA QUE COMPRENDE UN PRIMER INGREDIENTE ACTIVO QUE ES PONESIMOD Y UN SEGUNDO INGREDIENTE ACTIVO QUE SE SELECCIONA DEL GRUPO QUE CONSISTE EN TERIFLUNOMIDA Y LEFLUNOMIDA. The present invention relates to a pharmaceutical combination comprising a first active ingredient which is ponesimod and a second active ingredient which is selected from the group consisting of teriflunomide and leflunomide.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_CL2019002525A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Combinación farmacéutica que comprende ponesimod
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T06%3A37%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CLOZEL,%20Martine&rft.date=2020-02-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECL2019002525A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true